User menu

A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.

Bibliographic reference De Mits, Sophie ; Lenaerts, Jan ; Vander Cruyssen, Bert ; Mielants, Herman ; Westhovens, René ; et. al. A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.. In: PLoS One, Vol. 11, no. 11, p. e0166607 [1-10] (2016)
Permanent URL http://hdl.handle.net/2078.1/182815
  1. Barton Jennifer, Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy, 10.2147/ppa.s5835
  2. Rau R, Simianer S, van Riel PLCM, van de Putte LBA, Krüger K, Schattenkirchner M, Allaart CF, Breedveld FC, Kempeni J, Beck K, Kupper H, Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate, 10.1080/03009740410005467
  3. W Demary, Patient preference and adherence, 8, 1061 (2014)
  4. Genovese M. C., Covarrubias A., Leon G., Mysler E., Keiserman M., Valente R., Nash P., Simon-Campos J. A., Porawska W., Box J., Legerton C., Nasonov E., Durez P., Aranda R., Pappu R., Delaet I., Teng J., Alten R., Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate : Subcutaneous Abatacept Versus Intravenous Abatacept, 10.1002/art.30463
  5. TAYLOR P. C., RITCHLIN C., MENDELSOHN A., BAKER D., KIM L., XU Z., MACK M., KREMER J., Maintenance of Efficacy and Safety with Subcutaneous Golimumab Among Patients with Active Rheumatoid Arthritis Who Previously Received Intravenous Golimumab, 10.3899/jrheum.110570
  6. GR Burmester, Ann Rheum Dis (2015)
  7. TK Huynh, Patient preference and adherence, 8, 93 (2014)
  8. AP Malaviya, Patient preference and adherence, 6, 589 (2012)
  9. M Jeffery, ANNALS OF THE RHEUMATIC DISEASES, 63, 510 (2004)
  10. Chilton Frances, Collett Raymond A., Treatment choices, preferences and decision-making by patients with rheumatoid arthritis, 10.1002/msc.110
  11. Scarpato S., Antivalle M., Favalli E. G., Nacci F., Frigelli S., Bartoli F., Bazzichi L., Minisola G., Matucci Cerinic M., , Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study), 10.1093/rheumatology/kep354
  12. Williams E. L., Edwards C. J., Patient preferences in choosing anti-TNF therapies-R1, 10.1093/rheumatology/kel369
  13. Striesow Frank, Brandt Andreas, Preference, satisfaction and usability of subcutaneously administered methotrexate for rheumatoid arthritis or psoriatic arthritis: results of a postmarketing surveillance study with a high-concentration formulation, 10.1177/1759720x11431004
  14. Augustovski Federico, Beratarrechea Andrea, Irazola Vilma, Rubinstein Fernando, Tesolin Pablo, Gonzalez Juan, Lencina Verónica, Scolnik Marina, Waimann Christian, Navarta David, Citera Gustavo, Soriano Enrique R., Patient Preferences for Biologic Agents in Rheumatoid Arthritis: A Discrete-Choice Experiment, 10.1016/j.jval.2012.11.007
  15. Fraenkel L, Patient preferences for treatment of rheumatoid arthritis, 10.1136/ard.2003.019422
  16. RH Martin, The Journal of rheumatology, 35, 618 (2008)
  17. Zhang Jie, Xie Fenglong, Delzell Elizabeth, Chen Lang, Kilgore Meredith L., Yun Huifeng, Saag Kenneth G., Lewis James D., Curtis Jeffrey R., Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program : Biologic Agents Among US Medicare Beneficiaries With RA, 10.1002/acr.22055
  18. J Smolen, Ann Rheum Dis, 0, 1 (2013)
  19. Garneau Katie, Iversen Maura, Jan Saira, Parmar Kavita, Tsao Peter, Solomon Daniel H., Rheumatoid Arthritis Decision Making : Many Information Sources but Not All Rated as Useful, 10.1097/rhu.0b013e318226a220
  20. P Willeke, Zeitschrift fur Rheumatologie, 70, 232 (2011)
  21. Curran D., Bacchi M., Schmitz S. F. Hsu, Molenberghs G., Sylvester R. J., Identifying the types of missingness in quality of life data from clinical trials, 10.1002/(sici)1097-0258(19980315/15)17:5/7<739::aid-sim818>3.0.co;2-m
  22. Joffe M. M., Rosenbaum P. R., Invited Commentary: Propensity Scores, 10.1093/oxfordjournals.aje.a010011